Wager, US
David J. Wager, Jericho, VT US
| Patent application number | Description | Published |
|---|---|---|
| 20090129191 | Structure for SRAM voltage control for improved operational margins - A design structure including a static random access memory (“SRAM”) is provided which includes a plurality of SRAM cells arranged in an array. The array includes a plurality of rows and a plurality of columns. The SRAM includes voltage control circuits corresponding to respective ones of the plurality of columns of the array, each coupled to an output of a power supply. Each voltage control circuit temporarily reduces a voltage provided to power supply inputs of a plurality of SRAM cells that belong to a selected column of columns of the SRAM. The power supply voltage to the selected column is reduced during a write operation in which a bit is written to one of the SRAM cells belonging to the selected column. | 05-21-2009 |
| 20090327620 | CIRCUIT STRUCTURE AND METHOD FOR DIGITAL INTEGRATED CIRCUIT PERFORMANCE SCREENING - Disclosed is a semiconductor chip with a digital integrated circuit, such as a memory device (e.g., static random access memory (SRAM) arrays, dynamic random access memory (DRAM) arrays, content addressable memory (CAM) arrays, etc), that can be selectively operated in either a functional mode or in a performance screening mode. In the functional mode, a first signal supplied by an external signal generator is used to activate a first device in the circuit and, in response, a second device in the circuit outputs a data output signal. In the performance screening mode, a second signal is internally generated by an internal signal generator based on the data output signal. This second signal is then used to activate the first device in the circuit and, in response, the second device outputs the data output signal. Thus, in the performance screening mode, the digital integrated circuit is effectively converted into a performance screen ring oscillator (PSRO), the output of which can be monitored to determine whether performance criteria for the digital integrated circuit are met. | 12-31-2009 |
Donald Joseph Wager, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120128995 | Material for use with a capacitive touch screen - A modified material for use with a capacitive touch screen is described. The modified material comprises a material impregnated with a composition comprising either a non-metallic and/or a metallic conductive agent with a binder. A variety of materials are contemplated, including, but not limited to leather. Also described is an apparatus and method of providing a conductive glove is disclosed. | 05-24-2012 |
Donald Joseph Wager, Johnstown, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20120308806 | Material for use with a capacitive touch screen - A modified material for use with a capacitive touch screen is described. The modified material comprises a material impregnated with a composition comprising either a non-metallic and/or a metallic conductive agent with a binder. A variety of materials are contemplated, including, but not limited to leather. Also described is an apparatus and method of providing a conductive glove is disclosed. | 12-06-2012 |
Douglas W. Wager, Kansas City, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20100179834 | MANAGING RELATED ELECTRONIC MEDICAL RECORDS - Systems, methods, and computer-readable media for a method for linking the health records of two or more patients and alerting them of a change in at least one of the patient's health records are provided. One method comprises, in part, receiving an indication of a desire to link the first medical record of the first patient to a second medical record of a second patient and searching a connected health network for at least one of the first medical record associated with the first patient or the second medical record associated with the second patient. The method further comprises designating a sharing level between the first medical record of the first patient and the second medical record of the second patient, the sharing level indicating an extent of healthcare information that can be shared between the first medical record and the second medical record. The method also includes requesting the second patient to accept a link between the first medical record and the second medical record, and linking the first medical record associated with the first patient and the second medical record associated with the second patient. | 07-15-2010 |
| 20100179835 | RELATING MULTIPLE ELECTRONIC HEALTH RECORDS - A computer-implemented method for alerting one or more members of a connected health network is provided, wherein the connected health network includes two or more members having linked medical records. The method includes receiving a change in a first health record of a first member, the first health record being linked to a second health record of a second member based on a specified relationship. The method also includes using the change in the first health record to determine whether a condition exists that could affect the second member, and, if so, alerting the second member of the affect of the change in the first health record on the second member. | 07-15-2010 |
Garrick Wager, Arvada, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20130265853 | SEISMIC DATA ACQUISITION IN A WIRELESS ARRAY WITH RAPID SOURCE EVENTS - A data collection system that is operable to read out seismic data collected at wireless acquisition modules in response to source events such that the progression of subsequent source events occurs prior to the complete data record for a prior source event being collected at a data collection unit. The system may include mechanisms by which the source event progression is only interrupted based on a detected potential for loss of data integrity. | 10-10-2013 |
| 20140057660 | WIRELESS NETWORK WITH ADAPTIVE AUTONOMOUS LOCATION PUSH - A method of providing location-based services includes transmitting a first location criterion from a wireless network server to a wireless device. The method also includes evaluating whether a physical location of the wireless device satisfies the first location criterion. The process of evaluating is performed in part using the wireless device. When the first location criteria is satisfied, the method further includes transmitting an indication from the wireless device to the server that the first location criterion has been satisfied. | 02-27-2014 |
Gebhard Charles Wager US
| Patent application number | Description | Published |
|---|---|---|
| 20150129347 | METHODS AND APPARATUS FOR INDEPENDENTLY VARIABLE TORQUE DISTRIBUTION TO MOTOR VEHICLE DRIVE WHEELS - A wheel clutch includes a clutch pack mounted in a housing wherein either the friction plates or clutch plates of the clutch pack are fixed for rotation with a corresponding drive wheel, and the other of the friction plates or clutch plates is fixed for rotation with a drive shaft of the vehicle, a resilient member within the clutch housing normally biasing the clutch pack into a fully locked mode, a selectively actuable actuator within the clutch housing engaging the resilient member to selectively and progressively reduce a resilient force or to selectively and progressively allow the increase of the resilient force applied by the resilient member to the clutch pack, whereby the clutch pack is completely or progressively unlocked or locked respectively to provide an optimized amount of rotational traction versus rotational slippage. | 05-14-2015 |
James Wager, Richmond, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20120210966 | FUEL ADDITIVES TO MAINTAIN OPTIMUM INJECTOR PERFORMANCE - A diesel fuel additive package, diesel fuel containing the additive and methods for operating an engine on the diesel fuel and additive. The fuel additive includes a reaction product of (a) a hydrocarbyl substituted dicarboxylic acid or anhydride, and (b) an amine compound or salt thereof of the formula | 08-23-2012 |
Jeffrey D. Wager, Boston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20150320791 | SYSTEMS AND METHODS TO IMPROVE ORGAN OR TISSUE FUNCTION AND ORGAN OR TISSUE TRANSPLANT LONGEVITY - The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack. | 11-12-2015 |
John Wager, Corvallis, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20160075136 | THERMAL INKJET PRINTHEAD STACK WITH AMORPHOUS THIN METAL PROTECTIVE LAYER - The present disclosure is drawn to a thermal inkjet printhead stack with an amorphous thin metal protective layer, comprising an insulated substrate, a resistor applied to the insulated substrate, a resistor passivation layer applied to the resistor, and an amorphous thin metal protective layer applied to the resistor passivation layer. The amorphous thin metal protective layer can comprise from 5 atomic % to 90 atomic % of a metalloid of carbon, silicon, or boron. The film can also include a first and second metal, each comprising from 5 atomic % to 90 atomic % of titanium, vanadium, chromium, cobalt, nickel, zirconium, niobium, molybdenum, rhodium, palladium, hafnium, tantalum, tungsten, iridium, or platinum. The second metal is different than the first metal, and the metalloid, the first metal, and the second metal account for at least 70 atomic % of the amorphous thin metal protective layer. | 03-17-2016 |
John F. Wager, Corvallis, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20100289005 | AMORPHOUS MULTI-COMPONENT METALLIC THIN FILMS FOR ELECTRONIC DEVICES - An electronic structure comprising: (a) a first metal layer; (b) a second metal layer; (c) and at least one insulator layer located between the first metal layer and the second metal layer, wherein at least one of the metal layers comprises an amorphous multi-component metallic film. In certain embodiments, the construct is a metal-insulator-metal (MIM) diode. | 11-18-2010 |
| 20130092931 | THIN FILM TRANSISTORS - A thin-film transistor includes a gate electrode, a gate dielectric disposed on the gate electrode, a channel layer, and a passivation layer. The channel layer has a first surface and an opposed second surface, where the first surface is disposed over at least a portion of the gate dielectric. The channel layer also has a first oxide composition including at least one predetermined cation. The passivation layer is disposed adjacent to at least a portion of the opposed second surface of the channel layer. The passivation layer has a second oxide composition including the at least one predetermined cation of the first oxide composition and at least one additional cation that increases a bandgap of the passivation layer relative to the channel layer. | 04-18-2013 |
| 20140191197 | AMORPHOUS MULTI-COMPONENT METALLIC THIN FILMS FOR ELECTRONIC DEVICES - An electronic structure comprising: (a) a first metal layer; (b) a second metal layer; (c) and at least one insulator layer located between the first metal layer and the second metal layer, wherein at least one of the metal layers comprises an amorphous multi-component metallic film. In certain embodiments, the construct is a metal-insulator-metal (MIM) diode. | 07-10-2014 |
| 20140302310 | AMORPHOUS MULTI-COMPONENT METAL/METAL OXIDE NANOLAMINATE METAMATERIALS AND DEVICES BASED THEREON - Nanolaminates comprised of alternating layers of amorphous, multi-component metallic films (AMMFs) and metal oxide films are disclosed as metamaterials whose physical properties can be engineered to customize the resulting electrical, average dielectric, and thermal properties. In certain configurations using AMMFs, the construct may be an optical or an electronic element, such a metal-insulator-metal (MIM) diode, for example. | 10-09-2014 |
Joseph Wager, Boston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20150320791 | SYSTEMS AND METHODS TO IMPROVE ORGAN OR TISSUE FUNCTION AND ORGAN OR TISSUE TRANSPLANT LONGEVITY - The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack. | 11-12-2015 |
Ralph W. Wager, New Providence, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090166130 | Apparatus and Method for Securing Fall Arrest Equipment - An apparatus and method that allows a user to secure a fall arrest system to equipment in locations not originally intended to be used for fall safety equipment. By utilizing non-conventional anchor points to secure the fall arrest system, a user can provide adequate and compliant fall arrest protection on equipment without violating the environmental or structural integrity of the equipment. | 07-02-2009 |
| 20090169296 | Apparatus for Securing Fall Arrest Equipment - An apparatus and method that allows a user to secure a fall arrest system to equipment in locations not originally intended to be used for fall safety equipment. By utilizing non-conventional anchor points to secure the fall arrest system, a user can provide adequate and compliant fall arrest protection on equipment without violating the environmental or structural integrity of the equipment. | 07-02-2009 |
Ruth Wager, Rockville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20130309232 | VASCULAR ENDOTHELIAL GROWTH FACTOR 2 - Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof. | 11-21-2013 |
| 20140342405 | VASCULAR ENDOTHELIAL GROWTH FACTOR 2 - Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof. | 11-20-2014 |
Ruth E. Wager, Rockville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20080286288 | Vascular endothelial growth factor 2 - Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof. | 11-20-2008 |
| 20090023224 | Vascular endothelial growth factor 2 - Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof. | 01-22-2009 |
| 20110229466 | VASCULAR ENDOTHELIAL GROWTH FACTOR 2 - Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof. | 09-22-2011 |
| 20120213777 | VASCULAR ENDOTHELIAL GROWTH FACTOR 2 - Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof. | 08-23-2012 |
Scott Wager, Canandaigua, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100226259 | INTELLIGENT ROUTER FOR WIRELESS SENSOR NETWORK - Routing packets in a wireless security system. The system includes a network hub that wirelessly sends and receives packets, at least one sensor that wirelessly sends and receives packets to and from the network hub, and a packet router that monitors the packet communications between the network hub and the at least one sensor. The packet router determines when a communication failure occurs, and the packet router is configured to send a first message packet to the network hub if a first type of communication failure occurs and a second message packet to the at least one sensor if a second type of communication failure occurs. | 09-09-2010 |
Tor Wager, Boulder, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20160054409 | FMRI-BASED NEUROLOGIC SIGNATURE OF PHYSICAL PAIN - Described herein is a novel fMRI-based neurologic signature that predicts pain. Further described are methods for detecting pain, for diagnosing pain-related neuropathic conditions and for predicting or evaluating efficacy of an analgesic based on the neurologic signature. | 02-25-2016 |
Travis T. Wager, Brookline, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20140005183 | Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2 Inhibitors | 01-02-2014 |
| 20150366874 | Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d]Pyrimidines As LRRK2 Inhibitors - The present invention provides novel 4,5-disubstituted-7H-pyrrolo[2,3-d]pyrimidine derivatives of Formula I, and the pharmaceutically acceptable salts thereof | 12-24-2015 |
Travis T. Wager, New London, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090131433 | HISTAMINE-3 RECEPTOR ANTAGONISTS - This invention is directed to a compound of the formula Ia or Ib, as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing a compound of formula I, a method of treatment of a disorder or condition that may be treated by antagonizing histamine H3 receptors, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above, and a method of treatment of a disorder or condition selected from the group consisting of depression, mood disorders, schizophrenia, anxiety disorders, Alzheimer's disease, attention-deficit disorder (ADD), attention-deficit hyperactivity disorder (ADHD), psychotic disorders, sleep disorders, obesity, dizziness, epilepsy, motion sickness, respiratory diseases, allergy, allergy-induced airway responses, allergic rhinitis, nasal congestion, allergic congestion, congestion, hypotension, cardiovascular disease, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastro-intestinal tract, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above. | 05-21-2009 |
| 20110098272 | Novel Compounds As Casein Kinase Inhibitors - Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I | 04-28-2011 |
| 20120157440 | NOVEL FUSED PYRIDINE COMPOUNDS AS CASEIN KINASE INHIBITORS - Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: | 06-21-2012 |
| 20120220568 | Histamine-3 Receptor Antagonists - This invention is directed to a compound of formula I, | 08-30-2012 |
William Wager, Hillsboro, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20140310809 | PREVENTING MALICIOUS INSTRUCTION EXECUTION - Systems and techniques for preventing malicious instruction execution are described herein. A first instance of an instruction for a graphics processing unit (GPU) may be received. The instruction may be placed in a target list. A notification that the instruction caused a problem with the GPU may be received. The instruction may be moved from the target list to a black list in response to the notification. A second instance of the instruction may be received. The second instance of the instruction may be prevented from executing on the GPU in response to the instruction being on the black list. | 10-16-2014 |
| 20160063246 | PREVENTING MALICIOUS INSTRUCTION EXECUTION - Systems and techniques for preventing malicious instruction execution are described herein. A first instance of an instruction for a graphics processing unit (GPU) may be received. The instruction may be placed in a target list. A notification that the instruction caused a problem with the GPU may be received. The instruction may be moved from the target list to a black list in response to the notification. A second instance of the instruction may be received. The second instance of the instruction may be prevented from executing on the GPU in response to the instruction being on the black list. | 03-03-2016 |